TGM2 and neoplasm: The aim of the present study was to investigate the clinical significance of conventional and new markers (HJURP, HIF-1α, and TG2) in in situ breast cancer and in the tumor microenvironment and to assess any correlation with clinical outcome in patients homogeneously treated with surgery and postsurgery radiation therapy.